An Act concerning the regulation of Kratom
Massachusetts bill to establish state regulatory standards for kratom sales, labeling, and distribution to address product safety and consumer protection in an unregulated market.
Massachusetts bill to establish state regulatory standards for kratom sales, labeling, and distribution to address product safety and consumer protection in an unregulated market.
S 1609 proposes to regulate kratom—a plant-derived substance containing alkaloids with stimulant and opioid-like properties—in Massachusetts. The bill would establish state-level oversight of kratom's sale, labeling, and distribution, likely creating quality and safety standards similar to those for dietary supplements or controlled substances depending on the specific regulatory framework adopted.
Kratom use has grown significantly in the U.S., with consumers using it for pain relief, anxiety, and opioid withdrawal, but the substance remains largely unregulated at the federal level. Establishing state regulations affects consumer access, product safety, vendors' business practices, and could influence Massachusetts' broader approach to substances sitting in legal gray areas—while also potentially impacting individuals who rely on kratom as an alternative to prescription opioids.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.